Roche (RHHBY) Banks on New Drug Data to Defend Cancer Business
5/15/2013 10:45:33 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ZURICH, May 15 (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug, which loses patent protection in Europe later this year.
Help employers find you! Check out all the jobs and post your resume.